Oncology Today with Dr Neil Love

498 episodes

AKT Inhibition in Prostate Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
2026/09/05 | 17 mins.
Featuring perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics:
Tolerability of capivasertib and management of associated side effects — Question from Neeraj Agarwal, MD, FASCO (0:00)
Case: A man in his early 70s with Type 2 diabetes presents with metastatic hormone-sensitive prostate cancer with widespread bone metastases and PTEN deficiency on next-generation sequencing and receives relugolix/darolutamide — Rana R McKay, MD, FASCO (8:39)

CME information and select publications
ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists
2026/09/03 | 58 mins.
Featuring perspectives from Dr Lisa A Carey and Dr Maha Hussain, including the following topics:
Introduction (0:00)
HER2 History (1:32)
Cases from the GMO Survey (7:06)
Biology and Selection of First-Line Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer (mBC) — Dr Mahtani (19:56)
Faculty Case Presentations (31:37)
Patterns of Care Survey — Part 1 (38:26)
Optimizing the Use of Up-Front Maintenance Therapy for HER2-Positive mBC — Dr Carey (44:53)
Faculty Case Presentations (54:13)

CME information and select publications
Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program
2026/09/02 | 58 mins.
Featuring perspectives from Dr William G Wierda, including the following topics:
Introduction: Overview of the Grand Rounds Chronic Lymphocytic Leukemia Initiative (0:00)
Sequencing Road Map (12:39)
Key Datasets — Pirtobrutinib (21:08)
Investigator Survey (34:09)
Chimeric Antigen Receptor T-Cell Therapy (45:08)
Other Novel Therapy Approaches (49:58)
EHA 2026 (54:45)

CME information and select publications
Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal
2026/09/01 | 54 mins.
Featuring an interview with Prof Ticiana Leal, including the following topics:
Pathophysiology and clinical signs and symptoms (0:00)
Screening and/or diagnostic approaches (5:45)
Potential impact of available therapies for small cell lung cancer (SCLC) on paraneoplastic syndromes (7:36)
Key clinical trial data for amifampridine and practicalities of its administration (14:05)
Building awareness among patients, caregivers and the oncology community (22:37)
Role of pyridostigmine in managing Lambert-Eaton myasthenic syndrome (LEMS); potential integration of EMG (electromyography) into monitoring (25:35)
Case: A man in his early 70s who receives a diagnosis of limited-stage SCLC (LS-SCLC) with LEMS and undergoes treatment (27:41)
Case: A woman in her late 70s already diagnosed with LS-SCLC who is subsequently evaluated and treated for LEMS (37:55)
Current research and potential developments in the treatment of SCLC (48:32)

CME information and select publications
For Oncology Nurses: Prostate Cancer — Proceedings from the 2026 Annual ONS Congress
2026/08/31 | 1h 28 mins.
Featuring perspectives from Mr Michael Lai, Dr Scott T Tagawa, Ms Stacy E Walker and Dr Evan Y Yu, moderated by Dr Tagawa, including the following topics:
Introduction (0:00)
Overview of Prostate Cancer (3:00)
Hormonal Therapy for Nonmetastatic and Metastatic Hormone-Sensitive Prostate Cancer (HSPC) (6:12)
Potential Role of Capivasertib in Metastatic HSPC (27:22)
Current and Potential Future Role of PARP Inhibitors in Metastatic PC (46:39)
Current and Future Role of Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic PC (1:09:14)

CME information and select publications